BOSTON — A federal grand jury in Boston has been seated to investigate the Framingham compounding pharmacy that manufactured tainted steroid injections blamed for at least 36 deaths, according to a report.
The Boston Globe quotes several people familiar with the probe who say the grand jury has issued subpoenas to employees of the New England Compounding Center.
The sources, including one who has been called to testify, say subpoenas have also been issued for employees of Medical Sales Management of Framingham, which handled sales for the pharmacy.
A former Medical Sales Management salesman said he was interviewed Friday by agents from the Federal Bureau of Investigation about the sales and production practices of both companies.
The grand jury is expected to hear testimony from witnesses next week.
The Centers for Disease Control and Prevention says more than 500 people in 19 states have developed meningitis after receiving medication produced by the NECC.